Malfunction of vascular control in lifestyle-related diseases: Oxidative stress of angiotensin II-induced hypertension: Mitogen-activated protein kinases and blood pressure regulation

Journal of Pharmacological Sciences

Volumn 96, Issue 4, 2004, Pages 406-410

  Kimura, Shoji ^a   Zhang, Guo Xing ^a   Abe, Youichi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin; Mitogen activated protein kinase; Superoxide anion; Tempol; Vasoconstriction

Indexed keywords

ANGIOTENSIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TEMPOL;

BLOOD PRESSURE REGULATION; ENZYME ACTIVATION; HEMODYNAMICS; HYPERTENSION; LIFESTYLE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; SHORT SURVEY; SYMPATHETIC NERVE; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 12444257759     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FMJ04006X5     Document Type: Short Survey

References (28)

1. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
2. Wilson SK. Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ Res. 1990;66:722-734.
3. Rajagopalan S, Kurz S, Muzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
4. Ortiz P, Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol. 2002;283:F957-F962.
5. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension. 2002;37:547-553.
6. Rugale C, Delbosc S, Cristol J, Mimran A, Jover B. Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II. hypertension. Am J Physiol. 2003;284:H1744-H1750.
7. Lopez B, Salom MG, Arregui B, Valero F, Fenoy FJ. Role of superoxide in modulating the renal effects of angiotensin II. Hypertension. 2003;42:1150-1156.
8. Zanzinger J, Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflugers Arch. 2000;439:489-494.
9. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res. 2002; 91:1038-1045.
10. Bonini MG, Mason RP, Augusto O. The Mechanism by which 4-hydroxy-2,2,6,6-tetramethylpiperidene-1-oxyl (tempol) diverts peroxynitrite decomposition from nitrating to nitrosating species. Chem Res Toxicol. 2002;15:506-511.
11. Samuni A, Goldstein S, Russo A, Mitchell JB, Krishna MC, Neta P. Kinetics and mechanism of hydroxyl radical and OH-adduct radical reactions with nitroxides and with their hydroxylamines. J Am Chem Soc. 2002;124:8719-8724.
12. Nishida E, Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci. 1993;18:128-131.
13. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension. 1998;31:152-161.
14. Hu Y, Dietrich H, Metzler B, Wick G, Xu Q. Hyperexpression and activation of extracellular signal-regulated kinases (ERK1/2) in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 2000;20:18-26.
15. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 2000;19:6341-6350.
16. Muthalif MM, Karzoun NA, Gaber L, Khandekar Z, Benter IF, Saeed AE, et al. Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension. 2000;36:604-609.
17. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 1993;268:7388-7345.
18. Tsuda T, Kawahara Y, Ishida Y, Koide M, Shii K, Yokoyama M. Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells. Circ Res. 1992;71:620-630.
19. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1992;188:257-264.
20. Li Q, Dale WE, Hasser EM, Blaine EH. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am J Physiol. 1996;271: R2000-R2007.
21. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, et al. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension. 2003; 41:266-273.
22. Lavigne MC, Malech HL, Holland SM, Leto TL. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation. 2001;104:79-84.
23. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol. 2003;285: R277-R297.
24. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci. 2003;24:471-478.
25. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens. 2001;19: 1245-1254.
26. Laplante M-A, Wu R, Midaoui AE, de Champlain J. NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells. J Hypertens. 2003;21:927-936.
27. Mollnau H, Wendt M, Szöcs K, Lassegue B, Schulz E, Oelze M, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res. 2002;90:e59-e65.
28. phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:511-515.